// App-Quantinova.ai

: A Window Study of Acalabrutinib Plus Rituximab Followed By R-Dhaox (rituximab, dexamethasone, cytarabine, oxaliplatin) and Autologous Stem Cell Transplant (ASCT) in Fit Mantle Cell Lymphoma (MCL): The Australasian Leukaemia & Lymphoma Group (ALLG) NHL33 Wamm Trial

Researchers

Presenter

  • Eliza Hawkes

Principal Investigators

  • Shivam Agrawal

  • Sze-Ting Lee

  • Joel Wight

  • Greg Hapgood

  • Tasman Armytage

  • Nicole Wong Doo

  • Tara Cochrane

  • Chan-Yoon Cheah

  • Ian Bilmon

  • Matthew Ku

  • Stephen Opat

  • Bianca Devitt

  • Chun Yew Fong

  • Tineke Fancourt

  • Mannu Walia

  • Gloria Nkhoma

  • Allison Barraclough

Medical Centers

  • Australasian Leukaemia and Lymphoma Group, Richmond, Australia

  • Gosford Hospital, Gosford, Australia

  • Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia

  • Eastern Health Clinical School, Monash University, Melbourne, Australia

  • Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia

  • Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Melbourne, Australia

  • Townsville University Hospital, Douglas, Australia

  • Department of Haematology, Gold Coast University Hospital, Southport, Australia

  • St Vincent's Private Hospital Melbourne, Melbourne, Australia

  • Department of Clinical Haematology, Austin Health, Heidelberg, Australia

  • Concord Repatriation and General Hospital, Sydney, Australia

  • Monash Health, Clayton, Australia

  • Department of Haematology and Bone Marrow Transplantation, Westmead Hospital, Sydney, Australia

  • Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mantle cell lymphoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • ACP-196

  • Oxaliplatin

  • Carmustine

  • Cytarabine liposomal

  • Etoposide

  • Etoposide phosphate

  • Melphalan

  • Rituximab

  • Sandolase

Outcome

  • N/A

Study Design

  • Safety

  • Single Arm

  • Multicenteric

  • Investigator Initiated

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved